Clinical Trial Update: ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study [NA]

View source ↗

Summary

Dose-timing study evaluating indocyanine green (ICG) fluorescence imaging for intraoperative evaluation of breast cancer margins, sponsored by Jules Bordet Inst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | NA | Status: RECRUITING